Schönmann et al., 2020
ViewPDF| Publication | Publication Date | Title |
|---|---|---|
| Schönmann et al. | Adverse reactions during procedures: hypersensitivity to contrast agents and dyes | |
| Brockow et al. | Hypersensitivity to contrast media and dyes | |
| Orchard et al. | Pheohromocytoma—continuing evolution of surgical therapy | |
| Omura et al. | Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan | |
| Tippins et al. | Are screening serum creatinine levels necessary prior to outpatient CT examinations? | |
| Solomon | The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients | |
| Nguyen et al. | Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function | |
| Wilson et al. | Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study | |
| Rawson et al. | When to order contrast-enhanced CT | |
| US20030165428A1 (en) | Methods and compositions comprising monitoring devices | |
| Deepak et al. | Radiographical evaluation of ulcerative colitis | |
| Wulf et al. | Iodine allergy: common misperceptions | |
| Barron et al. | Rapid diagnostic imaging of acute, nonclassic appendicitis by leukoscintigraphy with sulesomab, a technetium 99m–labeled antigranulocyte antibody Fab′ fragment | |
| Holowka et al. | Use and safety of gadolinium based contrast agents in pediatric MR imaging | |
| Palmiere et al. | Allergic reactions following contrast material administration: nomenclature, classification, and mechanisms | |
| Maloney et al. | Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? | |
| Hagan | Anaphylactoid and adverse reactions to radiocontrast agents | |
| Maloney et al. | Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions | |
| Savarino et al. | Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: which implications in patients with Crohn’s disease? | |
| Madsen et al. | Inflammatory Bowel Disease Evaluated by Low-Field Magnetic Resonance Imaging Comparison with Endoscopy, 99m Tc-HMPAO Leucocyte Scintigraphy, Conventional Radiography and Surgery | |
| Böhm et al. | Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence | |
| Farmakis et al. | Safety of gadoterate meglumine in children younger than 2 years of age | |
| Mbanya et al. | Diabetes cost in sub-Saharan Africa | |
| Abbas et al. | “Contrast nephropathy” in renal transplantation: Is it real? | |
| Parisinos et al. | Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort study |